US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper published a salacious investigative report alleging the company intentionally ...

A spokesperson for UnitedHealth Group said. "The Guardian refused to engage with the truth and chose instead to print its ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

UnitedHealthcare sued The Guardian and its parent on Wednesday for defamation, claiming the US version of the British daily newspaper ran information it knew to be incorrect in ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based care companies are at risk.

UnitedHealth Group (NYSE: UNH) signaled confidence in its merger with Amedisys (Nasdaq: AMED) in a document prepared for shareholders. An earlier draft of ...

UnitedHealth said that Hemsley intends to stay on as CEO for at least three years. Its governance committee reviews and ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

UnitedHealth Group (NYSE: UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected all current directors: Charles Baker, ...

Stephen Hemsley previously served as CEO from 2006 through 2017 and has chaired the UnitedHealth Group board since 2017.